GT20029 matching placebo

DRUG2 trials

Sponsors

Suzhou Kintor Pharmaceutical Inc,

Conditions

AcneAlopeciaMale Pattern Hair Loss

Phase 1

To Evaluate the Safety, Tolerability and PK of GT20029 Gel and Solution in Healthy Subjects

CompletedNCT06468579

Suzhou Kintor Pharmaceutical Inc,Acne, Alopecia

Start: 2021-07-25End: 2023-04-26Updated: 2024-10-23

Phase 2

To Evaluate the Efficacy and Safety of GT20029 Solution in the Treatment of Androgenetic Alopecia (AGA) in Chinese Adult Males

CompletedNCT06692465

Suzhou Kintor Pharmaceutical Inc,Alopecia, Male Pattern Hair Loss

Start: 2023-04-13End: 2024-06-30Updated: 2024-11-18